Skip to main content.

Explore Study Opportunities

At the KU Alzheimer's Disease Research Center, we're doing more than imagining the future. We're doing the work to make it real. Join us and be part of the progress.

To learn how you or a loved one can take part in a study, call 913-588-0555 (option 1) or complete the Sign Me Up! form online.

KU Alzheimer’s Disease Center Clinical Cohort

A National Institute of Health (NIH) grant-funded study to develop and maintain a well characterized group of individuals to support further research on memory and aging.

Type of Study: Observational (no treatment)

Who can participate? Individuals with memory loss age 50 and older

What are the procedures? Clinical memory assessment, pen and paper test, blood draw

How long is participation? A long-term longitudinal study with up to 3 visits annually

Is there compensation? No

Cohort Study Flyer


Alzheimer’s Disease Neuroimaging Initiative 4 (ADNI 4)

Since its launch in 2004, the Alzheimer's Disease Neuroimaging Initiative (ADNI) study has been validating biomarkers for Alzheimer's disease (AD) clinical trials. ADNI4 continues the previously funded ADNI1, ADNI-GO, ADNI2, and ADNI3 studies. ADNI is an observational research study, which means it has no study drug or intervention. This study is designed to look at the relationship between clinical, cognitive, imaging, genetic, and biomarker tests to learn more about brain health and the full spectrum of Alzheimer’s disease (AD) from its earliest stages. The ADNI study will enroll participants from three groups:

    • Cognitively Normal (CN) group: individuals with no apparent memory problems.
    • Mild Cognitive Impairment (MCI) group: individuals diagnosed with early or late stages of mild memory problems.
    • Dementia (DEM) group: individuals diagnosed with a mild stage dementia.

Type of Study: Observational (no treatment)

Who can participate?  Individuals with normal cognition age 65-90 and individuals with Mild Cognitive Impairment or mild Alzheimer’s disease age 55-90

What are the procedures? Procedures include questionnaires, cognitive testing, MRI scans, PET scans, fasting blood draws, and optional lumbar punctures.

How long is participation? Five years with an option to continue enrollment.

Is there compensation?  Yes

Why is this resarch being done? Research studies are designed to help answer questions that will contribute to the Alzheimer’s disease research field.  The ADNI study is designed to determine the relationships between the clinical, cognitive, imaging, genetic, and biochemical biomarker characteristics of Alzheimer’s Disease.

ADNI 4 Study Flyer


Bioenergetic - Neural Pathways of Gait in Alzheimer Disease (NeruoWalk)

This study explores the connection between walking and cognition for those with Alzheimer's disease (AD).

Who can participate? Individuals with a diagnosis of Alzheimer's Disease

What are the procedures? Cognitive assessment, blood draws, questionnaires, walk and balance testing

How long is participation? This is a one-time visit lasting approximately 2.5 hours

How many study visits are there? One

Is there compensation? Yes

Why is this research being done?  This research is about how Alzheimer's disease affects walking and thinking abilities. We are looking at how energy production in cells (mitochondria) might be linked to these issues.

NeuroWalk Study Flyer

AvoCog

Avocados contain many nutrients beneficial for the brain. The AvoCog Study is a 12-week dietary intervention trial, that includes the consumption of avocados. Participants will have a total of four in-person study visits at The University of Kansas Medical Center campus. These visits will include various assessments, including MRI, blood sampling, questionnaires, and memory and thinking tests.

Who can participate? Older adults aged 65-85 who eat less than 2 avocados per month.

What are the study procedures?

  • Questionnaires
  • Blood Draws
  • Memory and thinking tests
  • MRI
  • Veggie Meter

How long is participation? 1-2 weeks for screening and 12 weeks of participation

How many visits are there? Four

Is there compensation? Yes

Why is this research being done? As the older adult population ages, there are more individuals are affected by cognitive decline. Lifestyle factors like diet may modulate cognitive health indicators. Avocados are a nutrient dense, brain-healthy food that may positively impact brain health and function. We want to understand if avocado consumption impacts memory and thinking in this population.

AvoCog Study Flyer


Therapeutic Diets in Alzheimer's Disease (TDAD)

We are interested in learning about the possible brain benefits of a heart-healthy or ketogenic eating pattern. Participants will follow either a ketogenic (high fat, low carb) or heart-healthy eating pattern for three months.

Who can participate? Individuals aged 50-90 with MCI or Alzheimer's Disease who have a study partner

What are the procedures? Physical exam, blood draws, questionnaires, cognitive testing, MRI, urine testing

How long is participation?  Three months of diet intervention and one-month follow-up phone call with up to seven visits for the exams, blood draws, testing, and imaging procedures

How many visits are there? Yes

Is there compensation? A maximum of seven visits

Why is this research being done? We are hoping to learn more about the nutritional benefits of a heart-healthy diet and a KETO diet for those with dementia. This information will help us to improve the diet of those who Alzheimer’s disease.

TDAD Study Flyer


Combined Exercise Trial (COMET)

A study to test whether endurance training, weight lifting, or both have independent and combined benefits for brain and body health as we age.

Type: Moderate intensity endurance exercise, weight training or both

Who can participate? Underactive individuals age 65+ 

What are the study procedures? Physical exam, computer and paper tests, questionnaires, blood collection, fitness tests, and MRI

How long is participation? 12 months of intervention

Is there compensation? Yes

COMET Study Flyer

AHEAD A3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment with BAN2401 in subjects (AHEAD)

A study to determine whether treatment with the study drug, BAN2401, is safe and effective in preventing or delaying the onset of Alzheimer's disease in individuals with higher risk for developing the disease.

Type of Study: Investigational medicine (chance of placebo)

Who can participate? Individuals age 55-80 years old who have risk factors for Alzheimer’s disease

What are the study procedures? MRI's, PET scans, pen and paper tests, questionnaires, blood draws, infusions, physical/neurological exams, optional lumbar puncture

How long is participation? 4 1/2 years

Is there compensation: Yes

AHEAD Study Flyer


SHIMMER COG1201

The COG1201 “Shimmer” study is a medication trial assessing the safety of CT1812 (pill medication) as a possible treatment for people diagnosed with mild to moderate dementia with Lewy Bodies. Click here to learn more.

Type of Study: Investigational medicine (chance of placebo)

Who can participate? Individuals of age 50-85 and diagnosed with mild to moderate dementia with Lewy Bodies

What are the study procedures? Blood draws, physical exams, pen and paper tests, infusions, MRI’s, PET scans, lumbar punctures, and other assessments as needed

How long is participation? Attend 12 study visits over approximately 8 months

Is there compensation?  Yes

SHIMMER COG1201 Study Flyer


CareTEXT Program: Eliminating barriers to dementia caregiver support access in Cass, Clay, Jackson, Platte, and Ray counties

This non-research, text-based program supports caregivers of people with dementia (available in English and Spanish). 

Ver esta página en Español

Type of Study: This is a quality improvement program, not a research study. Program participants will receive educational and skill-building text messages to support their caregiving including the ability to chat with a trained coach who can help connect participants with resources.

Who can participate? Caregivers of individuals with dementia in Cass, Clay, Jackson, Platte, and Ray counties

What are the procedures? Two phone calls, not in person. (baseline and 6-mo. follow up)

How long is the program? Six months

Is there compensation? No

CareTEXT study flyer

CuidaTEXT study flyer


Down Syndrome Cohort

Study overview:  The Down syndrome Cohort study is a long-term, observational study. The goal of the Down syndrome Cohort study is to follow a group of participants with Down syndrome over time to learn more about brain health related to aging. This study collects a broad range of detailed information from each participant to support further research on individuals with Down syndrome in relation to aging, cognition, dementia, and Alzheimer’s Disease.

Who can participate?  Adults with Down syndrome who are 18 years old or older and have a study partner who is able to attend study visits with the participant.

What are the study procedures? There are three visits within three months and some visits can be combined

  • Clinical Evaluation to collect health history, family history, questionaries, brief non-invasive physical and neuro exam, vitals
  • Fasting Laboratory Blood Draw
  • Memory and Thinking Evaluation

How long is participation? This is a long-term longitudinal study.

How many visits are there? Three visits every 16 months

Is there compensation? Yes

Why is this research being done?  The purpose of this study is to learn more about people who have Down syndrome and their brain health. The information collected will help to contribute to local, regional, and national research studies.

Down Syndrome Cohort Study Flyer


Trial Ready Cohort - Down Syndrome 

Study overview:  The Trial Ready Cohort-Down Syndrome or TRC-DS matches adults with Down syndrome to Alzheimer’s disease clinical trials designed specifically for people with Down syndrome. Volunteers will become a part of a community of clinical trial volunteers who can help to find a cure for Alzheimer’s disease.

Who can participate?  Adults with Down syndrome who are between the ages of 25-55 and have no memory impairment.

What are the study procedures?

  • Screening
    • Blood draws, MRI and PET scans, questionnaires, and a cognitive assessment.
  • Baseline
    • Questionnaires, cognitive assessment, blood draw, PET, and optional lumbar puncture
  • 16 – Month Follow Up
    • Questionnaires, cognitive assessment, blood draw, MRI and PET, and optional lumbar puncture

How long is participation?  Every 16 months until the participant is matched with an Alzheimer’s disease clinical trial.

How many visits are there?  Initial screening and baseline visits followed by a regular visit every 16 months until enrollment in a clinical trial.

Is there compensation? Yes

Why is this research being done?  Alzheimer’s disease occurs more frequently in people with Down syndrome because they have an extra copy of chromosome 21. As many as 9 in 10 people with Down syndrome develop Alzheimer’s disease. Through routine screenings, researchers can fast-track TRC-DS volunteers for enrollment in qualifying clinical studies in hope of finding a cure for Alzheimer’s disease in people with Down syndrome.

Trial Ready Cohort - DS Study Flyer


Brain Outcomes and Lifestyle in Down Syndrome (BOLD)

Study overview: The BOLD study is a two-visit observational study. The goal of this study is to learn more about how diet impacts brain health among those with Down syndrome. This study collects a broad range of detailed information from each participant to support further research on individuals with Down syndrome in relation to aging, cognition, dementia, and Alzheimer’s Disease.

Who can participate? Adults with Down syndrome who are 18 years old or older, have a BMI of 25 or greater and have a study partner who is able to attend study visits with the participant.

What are the study procedures?  There are up to three study visits over one month period and some visits can be combined, the visits will involve the following:

  • Fasting Laboratory Blood Draw
  • Memory and Thinking Evaluation
  • Evaluation of Diet, Physical activity, and weight
  • MRI
  • Caregiver questionnaires

How long is participation? Up to one month

How many visits are there? Two in-person and one remote visit in a one-month period

Is there compensation? Yes

Why is this research being done?  The purpose of this study is to conduct an initial evaluation of the impact of weight loss and diet quality on factors that may delay the development of Alzheimer’s disease in adults with Down syndrome.

BOLD Study Flyer


SPARTANS

Study overview: SPARTANS will collect physical activity measures to help find better ways to measure movement in adults with Down syndrome. Volunteers will be asked to attend one study visit that lasts about two hours.

Who can participate? Adults with Down syndrome who are 18 years or older.

What are the study procedures? Height, weight, measurement of movement intensity through preforming everyday household activities and exercise.

How long is participation?  Single visit lasting about 2 hours.

How many visits are there? One visit.

Is there compensation? Yes

Why is this research being done?  The University of Kansas Alzheimer’s Disease Research Center is wanting to find better ways to measure movement in adults with Down syndrome while they do everyday activities.


ABATE

Study overview: People with Down syndrome often develop Alzheimer’s disease as they get older. The ABATE study is a clinical trial testing an investigational vaccine to see if it slows the progression in individuals with Down syndrome.

We want to see:

  • If the vaccine is safe
  • How the vaccine works inside the body
  • If it helps get rid of amyloid buildup
  • If it slows down memory loss and thinking problems

Who can participate? Cognitively Normal (CN) group: individuals with no apparent memory problems.

What are the study procedures? Procedures include questionnaires, cognitive testing, ECG, MRI scans, PET scans, blood draws, and optional lumbar punctures.

How long is participation? Approx 2 Years (106 weeks)

How many visits are there? Approx 20 visits (some visits may be broken up into more or combined into less.)

Is there compensation? Yes

Why is this research being done? Individuals with Down syndrome often get Alzheimer’s disease when they get older. Alzheimer’s disease occurs when a protein called amyloid builds up in the brain. Right now, there is no treatment available for Alzheimer’s disease in individuals with Down syndrome. The ABATE study wants to test an investigational vaccine to see if it slows down memory loss and thinking problems.

ABATE Study Flyer

Take the First Step

Make a difference. Become a research hero. 

Consider me for a study

Contact Us

Do you have questions about participating in a research study? Want to talk with someone at KU Alzheimer's Disease Research Center?
Contact Us
KU Alzheimer's Disease Research Center

KU Clinical Research Center
4350 Shawnee Mission Parkway
Mailstop 6002
Fairway, KS 66205
913-588-0555
Email: kuadrc@kumc.edu